Randomized Evaluation of Octreotide Versus Compazine for Emergency Department Treatment of Migraine Headache

NCT00274170 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

56

Enrollment

FED

Sponsor class

Conditions

Migraine Headache

Interventions

DRUG: Octreotide

Sponsor

C.R.Darnall Army Medical Center